Xylem (NYSE: XYL) reported Q4 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.03 billion.

Xylem sees FY2015 EPS of $1.85-$1.95, versus the consensus of $2.03.

For earnings history and earnings-related data on Xylem (XYL) click here.